These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30643839)

  • 21. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma.
    Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M
    Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vanishing Bile Duct Syndrome Associated With Estrogen.
    Benfield J; Shah RA; Grider DJ; Sahebjam F
    ACG Case Rep J; 2022 May; 9(5):e00776. PubMed ID: 35919669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
    Yeh P; Lokan J; Anantharajah A; Grigg A
    Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.
    Ballonoff A; Kavanagh B; Nash R; Drabkin H; Trotter J; Costa L; Rabinovitch R
    Acta Oncol; 2008; 47(5):962-70. PubMed ID: 17906981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.
    Barta SK; Yahalom J; Shia J; Hamlin PA
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):77-82. PubMed ID: 16879775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vanishing bile duct syndrome.
    Reau NS; Jensen DM
    Clin Liver Dis; 2008 Feb; 12(1):203-17, x. PubMed ID: 18242505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma].
    Córdoba Iturriagagoitia A; Iñarrairaegui Bastarrica M; Pérez de Equiza E; Zozaya Urmeneta JM; Martínez-Peñuela JM; Beloqui Pérez R
    Gastroenterol Hepatol; 2005 May; 28(5):275-8. PubMed ID: 15871809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.
    Zhao Z; Bao L; Yu X; Zhu C; Xu J; Wang Y; Yin M; Li Y; Li W
    Medicine (Baltimore); 2017 Sep; 96(36):e8009. PubMed ID: 28885366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vanishing bile duct syndrome in non-Hodgkin lymphoma: a case report.
    Foramiti S; Biondini E; Bigolin T; Pasca S; Rossi P
    Minerva Med; 2011 Aug; 102(4):345-9. PubMed ID: 21959708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection.
    Delladetsima JK; Makris F; Psichogiou M; Kostakis A; Hatzakis A; Boletis JN
    Liver; 2001 Apr; 21(2):81-8. PubMed ID: 11318976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
    Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
    Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanishing bile duct syndrome in a HIV patient on HAART therapy.
    Gnanaraj J; Fiedler P; Virata M
    BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
    Pass AK; McLin VA; Rushton JR; Kearney DL; Hastings CA; Margolin JF
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):976-80. PubMed ID: 19131796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.
    Cho HJ; Jwa HJ; Kim KS; Gang DY; Kim JY
    Pediatr Gastroenterol Hepatol Nutr; 2013 Dec; 16(4):273-8. PubMed ID: 24511525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.
    Arnold JC; Nouri-Aria KT; O'Grady JG; Portmann BC; Alexander GJ; Williams R
    Clin Investig; 1993 Mar; 71(3):191-6. PubMed ID: 8386961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drugs-associated vanishing bile duct syndrome: a real-world retrospective and disproportionality analysis.
    Wang J; Wu C; Deng Z
    Expert Opin Drug Saf; 2024 Oct; ():1-7. PubMed ID: 39394650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.